Health ❯ Healthcare ❯ Patient Care

Treatment Options

Oral Medications Innovative Therapies Combination Therapy Personalized Medicine Subcutaneous Administration Chemotherapy Endocrine Therapy Cognitive Impairment Targeted Therapy Immunotherapy

3 ARTICLES

yesterday

VA Shifts to Monitoring for Most Favorable‑Risk Prostate Cancers

A JAMA analysis credits the VA’s national electronic records with enabling the shift to surveillance while noting persistent gaps in access and counseling.

5 ARTICLES

last wk.

FDA Grants Accelerated Approval for RP1 (Tudriqev) With Nivolumab in Advanced Melanoma

3 ARTICLES

3w ago

FDA Approves Lytenava, First Ophthalmic Bevacizumab for Wet AMD

3 ARTICLES

3w ago

EU Advisers Back Susvimo Implant as New Option for Wet Age‑Related Macular Degeneration

3 ARTICLES

3w ago

FDA Approves Lipfendra, First Oral PCSK9 Pill to Lower LDL Cholesterol

31 ARTICLES

4w ago

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

5 ARTICLES

4w ago

FDA Approves Revtorpyk for HER2‑Low Breast Cancer but Launch and Safety Questions Loom

7 ARTICLES

4w ago

Melatonin Lowers Chronic Musculoskeletal Pain, University of Sydney Analysis Finds

3 ARTICLES

last mo.

FDA Grants Priority Review to Roche’s Enspryng for Thyroid Eye Disease

3 ARTICLES

last mo.

FDA Approves Lumvoa for Thyroid Eye Disease

3 ARTICLES

last mo.

Trodelvy Approved in U.S. and EU as First‑Line Option for Metastatic Triple‑Negative Breast Cancer

3 ARTICLES

last mo.

IGeL‑Monitor Finds No Clear Benefit From Osteopathy for Lower Back Pain

3 ARTICLES

last mo.

FDA Approves First Generic Single‑Dose Flu Drug

4 ARTICLES

2mo ago

FDA Grants Accelerated Approval to Sanofi’s Tzield for Children With Stage 3 Type 1 Diabetes

5 ARTICLES

2mo ago

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

6 ARTICLES

2mo ago

NHS to Roll Out Five-Session Precision Radiotherapy for Early Prostate Cancer

3 ARTICLES

2mo ago

UCSF Study Identifies Cellular Loop That Weakens Brain Aneurysms

Treatment Options

VA Shifts to Monitoring for Most Favorable‑Risk Prostate Cancers

FDA Grants Accelerated Approval for RP1 (Tudriqev) With Nivolumab in Advanced Melanoma

FDA Approves Lytenava, First Ophthalmic Bevacizumab for Wet AMD

EU Advisers Back Susvimo Implant as New Option for Wet Age‑Related Macular Degeneration

FDA Approves Lipfendra, First Oral PCSK9 Pill to Lower LDL Cholesterol

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

FDA Approves Revtorpyk for HER2‑Low Breast Cancer but Launch and Safety Questions Loom

FDA Approves At‑Home Weekly Subcutaneous Starter Dose for Leqembi

Late‑Stage Trial of Wainua Misses Primary Goal in ATTR‑CM Study

Welsh Hospital Ward Closed After Rare Scabies Outbreak

Never miss stories about

Treatment Options

Melatonin Lowers Chronic Musculoskeletal Pain, University of Sydney Analysis Finds

FDA Grants Priority Review to Roche’s Enspryng for Thyroid Eye Disease

FDA Approves Lumvoa for Thyroid Eye Disease

Trodelvy Approved in U.S. and EU as First‑Line Option for Metastatic Triple‑Negative Breast Cancer

IGeL‑Monitor Finds No Clear Benefit From Osteopathy for Lower Back Pain

FDA Approves First Generic Single‑Dose Flu Drug

FDA Grants Accelerated Approval to Sanofi’s Tzield for Children With Stage 3 Type 1 Diabetes

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

NHS to Roll Out Five-Session Precision Radiotherapy for Early Prostate Cancer

UCSF Study Identifies Cellular Loop That Weakens Brain Aneurysms

Never miss stories about

Treatment Options